TECH
Bio-Techne Corporation
- Healthcare
- US companies in Healthcare (47)
- NASDAQ · USD
- Mkt cap $11.4bn
$72.55
as of 23 Oct 2026, At its 52-week high
TECH
Screens as well placed to keep growing its dividend, with low cut-risk signals and looks somewhat extended against its own history.
These are a resilience check on the dividend, not a recommendation to buy or sell. They are not financial advice.
Quick check
Forward yield
0.44%
Earnings cover
3.6×
Pays 27% of earnings
Cash cover
5.3×
5-year growth
0.0%
Quality
95
Capacity to keep growing the dividend
Risk
0
Signals of dividend-cut pressure
Trim
60
How extended the valuation looks
How these scores are calculated (methodology)
See which signals drive each score
Pro members see the full per-signal breakdown behind the Quality, Risk, and Trim scores, plus score history as it builds. Informational only, not financial advice.
Sign in to start free trialScores are informational and refresh once a day. They are not financial advice, not a prediction of future returns, and not instructions to buy or sell. Always do your own research. See the Terms of Service.